Stock·NASDAQ·Technology
Allegro MicroSystems, Inc. (ALGM)
- Market cap
- $6.02B
- P/E
- 538.67
- Dividend yield
- None
- Street target
- $53.00median of 13 analysts
- 52-week range
- $22.41 $71.77
ALGM stock forecast today
Where ALGM stands today, and what CleaRank Financial AI makes of it.
ALGM at a glance
Allegro MicroSystems, Inc. (ALGM): Sell, 40/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($35.62 and $40.80).
- Insiders Insiders sold $6.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 538.7 against 35.1 for the Technology sector: a premium to peers (+1,435%).
Figures as of October 26, 2026.
CleaRank Financial AI
Allegro MicroSystems, Inc. (ALGM) receives a Sell rating from CleaRank, with a model score of 40/100.
The analysts' outlook lifts the score most: 12 of 13 analysts rate it a buy, and the median target is 64.0% above the price. The trend holds the score back most. The price is 20.78% below its 200-day average and 9.26% below its 50-day, and the 50-day sits 12.69% below the 200-day. The 50-day average is $35.62 and the 200-day is $40.80. Across the past year the price rose 4.56%.
Only on CleaRank
Figures we compute ourselves from ALGM's own price, earnings and insider-filing history. Tap one to see it in context.
ALGM stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $32.32 is 9.3% below the 50-day simple moving average of $35.62.Price above its 200-day average ›
The price is 20.8% below the 200-day simple moving average of $40.80.50-day average above the 200-day ›
The 50-day average ($35.62) is 12.7% below the 200-day average ($40.80), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 20% of its 52-week range, between $22.41 and $71.77.
ALGM share price
Pick a period: each tab shows how far ALGM has moved over it, to the last close.
Today's trading
Where ALGM sits inside today's range and its 52-week range.
ALGM fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/E below the sector median ›
The trailing P/E of 538.67 is 1,434.7% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 6.37 is 16.2% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $14.2M on revenue of $945.9M, a net margin of 1.5%.
Key statistics
The headline figures for ALGM.
As of October 26, 2026, ALGM trades at $32.32, with a market value of $6.02B and a P/E ratio of 538.67.
What the numbers say
CleaRank Financial AI's reading of ALGM's valuation, growth and risks.
Measured on sales, its P/S of 6.37 is 16.2% below the sector median P/S of 7.6. Allegro MicroSystems, Inc. carries a market value of $6.0B.
In the latest quarter, against the same quarter a year earlier, revenue grew 27.50%, 3.3 percentage points faster than the sector median of 24.2%. ALGM turns sales into profit at a net margin of 1.50% and an operating margin of 9.82%, alongside a return on equity of 1.53%, below the sector median of 13.4%. Debt-to-equity of 0.31 rounds out the fundamentals.
Looking ahead, analysts expect EPS of $1.03 this fiscal year (growth of 90.4%) and $1.50 the year after (growth of 46.0%).
The 30-day standard deviation of ALGM's daily returns is 3.30% with a beta of 1.99 against the S&P 500. Valuation leaves less margin for error: the P/E of 538.67 is 1,434.7% above the sector median, a premium to peers. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 54.97% below its 52-week high of $71.77.
ALGM against the Technology sector
How ALGM compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: ALGM trades at a significant premium to sector peers (+1,435%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 14, 2025, ALGM has gained 19.6% against a gain of 59.2% for XLK.
Performance against XLK
ALGM and the Technology sector fund over the same days.
Revenue and earnings
How much ALGM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.8% in FY2026 to $890M, from $725M a year earlier.
Profit margin: The net margin was -1.6% in FY2026, up from -10.0% the year before.
Loss-making: ALGM lost $14.7M in FY2026.
ALGM AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 40.8, in neutral territory.RSI above 50 ›
An RSI of 40.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of ALGM
The score, the reasoning behind it, and what could move the price next.
Allegro MicroSystems, Inc. (ALGM) is in a downtrend: both moving averages sit overhead, and the price of $32.32 is 9.26% below its 50-day average of $35.62 and 20.78% below its 200-day average of $40.80. The stock is at 20% of its 52-week range, leaving the price 44.22% above the 52-week low of $22.41. The 50-day average is 12.69% below the 200-day, a gap that supports the weak trend rather than offsetting it.
A recent pullback sits inside a stronger longer record: the price fell 12.08% over the past month, fell 30.94% over the past three months and rose 4.56% over the past year. The price rose 2.67% in the last session on volume 29.4% above its average. On momentum, the 14-day RSI reads 40.8, in the neutral zone, with the MACD line negative.
New analyst coverage ›
RBC Capital started coverage at Outperform on October 2, 2026.
Source: Analyst action, RBC Capital, October 2, 2026New analyst coverage ›
Benchmark started coverage at Buy on August 13, 2026.
Source: Analyst action, Benchmark, August 13, 2026Rating reaffirmed ›
Wells Fargo kept its Overweight rating on October 20, 2026.
Source: Analyst action, Wells Fargo, October 20, 2026
- The two closest levels matter most: the 20-day EMA at $34.01 sits above the price, and the 52-week low at $22.41 sits below it.
- The 14-day RSI is 40.8, which is neutral, and the MACD line is negative. Readings above 70 or below 30 would point to stretched momentum.
ALGM stays in a downtrend for as long as it trades under both its 50-day average at $35.62 and its 200-day average at $40.80. A close back above the 50-day would be the first sign of repair. Overhead, the 20-day EMA at $34.01 is the first barrier a rebound would meet.
ALGM's next level below the price is the 52-week low at $22.41.
Technical indicators
Momentum and trend for ALGM, from its daily closes.
As of October 26, 2026, with ALGM at $32.32, its 14-day RSI is 40.8 (neutral territory), its 50-day simple moving average is $35.62 and its 200-day is $40.80.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ALGM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, ALGM's 1-year correlation of daily returns is +0.57 with S&P 500 (SPY), +0.64 with Nasdaq 100 (QQQ), +0.20 with Bitcoin (BTC) and +0.17 with gold (XAU).
ALGM price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
12 of 13 analysts rate it a buy or strong buy, 1 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $53.00 is 64.0% above the price.More buy ratings than three months ago ›
12 of 13 rate it a buy now, against 10 of 11 three months ago.
ALGM Wall Street View
12-month price targets
The price, $32.32, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 20, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 19, 2026 | TD Cowen | Maintains | Buy |
| Oct 2, 2026 | RBC Capital | Initiates | Outperform |
| Aug 13, 2026 | Benchmark | Initiates | Buy |
| Jul 31, 2026 | Mizuho | Maintains | Outperform |
| Jul 31, 2026 | Morgan Stanley | Maintains | Overweight |
As of October 26, 2026, 13 Wall Street analysts cover ALGM: 12 rate it a buy or strong buy, 1 a hold and 0 a sell or strong sell. Their 12-month price targets range from $40.00 to $62.00. The median ALGM price target is $53.00, 64.0% above the price of $32.32.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ALGM trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ALGM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
ALGM moves about 3.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ALGM tends to move, against the market and on its own.
ALGM price history and drawdowns
ALGM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 3.30% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 68.2%, from July 2023 to April 2025, regained by June 2026.Most 1-year holds ended higher ›
52% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2020 is now worth $18,260, against $25,141 in the S&P 500 (SPY).
ALGM Drawdowns & Recovery
As of October 26, 2026, ALGM's worst peak-to-trough fall over the last 6 years with dividends reinvested was -68.2% (July 2023 to April 2025); it regained that peak by June 2026, 14 months after the low, and 52% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ALGM in October 2020 is worth now, against the same amount in the S&P 500.
Against the market: ALGM trailed the S&P 500 over this period: $18,260 against $25,141.
A $10,000 investment in ALGM in October 2020 would be worth about $18,260 today with dividends reinvested, compared with about $25,141 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ALGM, and which have not.
Strongest month, June: an average of +14.38%, up in 4 of 6 years.
Weakest month, July: an average of -6.80%, up in 2 of 6 years.
This month, October: has averaged -2.10%, up in 3 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, ALGM's strongest calendar month has been June (average +14.38%, up in 4 of 6 years) and its weakest July (average -6.80%, up in 2 of 6 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
ALGM stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ALGM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in ALGM today could grow to about $13,580 by 2030 in the base case, with a 90th-percentile outcome near $48,922 and a 10th-percentile outcome around $3,770. Projections are statistical simulations, not guarantees.
ALGM Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $43.89 for ALGM by 2030 in the base case, from $32.32 today (1.4x over 4 years). The 10th-percentile path ends near $12.18. These are outcomes of a Monte Carlo simulation run on ALGM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $18.38 | $34.89 | $66.22 | |
| 2028 | $15.22 | $37.66 | $93.22 | |
| 2029 | $13.40 | $40.66 | $123 | |
| 2030 | $12.18 | $43.89 | $158 |
Method: a lognormal simulation of ALGM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
ALGM insider trading
What the people running the company have bought and sold.
ALGM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought ALGM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, ALGM insiders reported 18 open-market sales worth $6.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Jennie Raubacher
Director
|
Sell | 1.0K | $45.3K |
| Aug 10, 2026 | Erin Hagen
Officer
|
Sell | 2.3K | $101.4K |
| Aug 5, 2026 | Joseph R Martin
Director
|
Grant | 4.3K | - |
| Aug 5, 2026 | Krishna G Palepu
Director
|
Grant | 4.3K | - |
| Aug 5, 2026 | Mary G Puma
Director
|
Grant | 4.3K | - |
| Aug 5, 2026 | Yoshihiro Suzuki
Director
|
Grant | 4.3K | - |
| Jun 17, 2026 | Brian C White
Director
|
Grant | 594 | - |
| Jun 3, 2026 | Richard Madormo
Officer
|
Sell | 5.0K | $263.6K |
| May 22, 2026 | Troy Coleman
Officer
|
Sell | 4.5K | $205.7K |
| May 21, 2026 | Roald Graham Webster
Officer
|
Sell | 5.2K | $234.2K |
| May 18, 2026 | Ian Kent
Officer
|
Sell | 2.6K | $109.8K |
| May 14, 2026 | Susan D. Lynch
Director
|
Sell | 16.7K | $759.6K |
| May 13, 2026 | Sharon Briansky
General Counsel
|
Grant | 18.5K | - |
| May 13, 2026 | Troy Coleman
Officer
|
Grant | 18.1K | - |
| May 13, 2026 | Derek P. D'Antilio
Chief Financial Officer
|
Grant | 59.9K | - |
| May 13, 2026 | Michael C Doogue
Chief Executive Officer
|
Grant | 160.8K | - |
| May 13, 2026 | Erin Hagen
Officer
|
Grant | 9.1K | - |
| May 13, 2026 | Ian Kent
Officer
|
Grant | 8.5K | - |
| May 13, 2026 | Richard Madormo
Officer
|
Grant | 19.8K | - |
| May 13, 2026 | Roald Graham Webster
Officer
|
Grant | 5.3K | - |
| May 13, 2026 | Robert Willett
Director
|
Grant | 1.1K | - |
| May 11, 2026 | Michael C Doogue
Chief Executive Officer
|
Sell | 30.1K | $1.4M |
| May 11, 2026 | Sharon Briansky
General Counsel
|
Sell | 8.9K | $425.4K |
| Mar 2, 2026 | Sharon Briansky
General Counsel
|
Sell | 9.7K | $340.4K |
| Mar 2, 2026 | Erin Hagen
Officer
|
Sell | 2.6K | $90.9K |
| Feb 17, 2026 | Sharon Briansky
General Counsel
|
Sell | 9.3K | $384.8K |
| Feb 2, 2026 | Ian Kent
Officer
|
Grant | 9.2K | - |
| Dec 10, 2025 | Sharon Briansky
General Counsel
|
Sell | 27.9K | $836.2K |
| Nov 11, 2025 | Troy Coleman
Officer
|
Grant | 73.5K | - |
| Aug 22, 2025 | Roald Graham Webster
Officer
|
Sell | 8.3K | $271.2K |
| Aug 12, 2025 | Richard R. Lury
Director
|
Sell | 7.0K | $222.7K |
| Aug 7, 2025 | Richard R. Lury
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Susan D. Lynch
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Joseph R Martin
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Krishna G Palepu
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Mary G Puma
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Jennie Raubacher
Director
|
Grant | 5.9K | - |
| Aug 7, 2025 | Yoshihiro Suzuki
Director
|
Grant | 5.9K | - |
| Aug 4, 2025 | Erin Hagen
Officer
|
Sell | 5.0K | $157.2K |
| Jun 11, 2025 | Richard R. Lury
Director
|
Sell | 3.1K | $94.4K |
| Jun 4, 2025 | Richard R. Lury
Director
|
Sell | 6.8K | $189.0K |
| May 15, 2025 | Sharon Briansky, J.D.
General Counsel
|
Grant | 35.1K | - |
| May 15, 2025 | Derek P. D'Antilio
Chief Financial Officer
|
Grant | 65.1K | - |
| May 15, 2025 | Michael C Doogue
Chief Executive Officer
|
Grant | 150.2K | - |
| May 15, 2025 | Erin Hagen
Officer
|
Grant | 18.2K | - |
| May 15, 2025 | Richard Madormo
Officer
|
Grant | 37.6K | - |
| May 15, 2025 | Roald Graham Webster
Officer
|
Grant | 9.8K | - |
| May 13, 2025 | Sharon Briansky, J.D.
General Counsel
|
Grant | 14.7K | - |
| May 13, 2025 | Derek P. D'Antilio
Chief Financial Officer
|
Grant | 21.3K | - |
| May 13, 2025 | Michael C Doogue
Chief Executive Officer
|
Grant | 18.5K | - |
| May 13, 2025 | Erin Hagen
Officer
|
Grant | 1.2K | - |
| May 13, 2025 | Roald Graham Webster
Officer
|
Grant | 1.0K | - |
Source: TwelveData, from SEC Form 4 filings
ALGM stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.